405 related articles for article (PubMed ID: 15488219)
1. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation.
Friesema EC; Grueters A; Biebermann H; Krude H; von Moers A; Reeser M; Barrett TG; Mancilla EE; Svensson J; Kester MH; Kuiper GG; Balkassmi S; Uitterlinden AG; Koehrle J; Rodien P; Halestrap AP; Visser TJ
Lancet; 2004 Oct 16-22; 364(9443):1435-7. PubMed ID: 15488219
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine.
Jansen J; Friesema EC; Kester MH; Milici C; Reeser M; Grüters A; Barrett TG; Mancilla EE; Svensson J; Wemeau JL; Busi da Silva Canalli MH; Lundgren J; McEntagart ME; Hopper N; Arts WF; Visser TJ
J Clin Endocrinol Metab; 2007 Jun; 92(6):2378-81. PubMed ID: 17356046
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8.
Friesema EC; Jansen J; Heuer H; Trajkovic M; Bauer K; Visser TJ
Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):512-23. PubMed ID: 16957765
[TBL] [Abstract][Full Text] [Related]
4. Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations.
Anık A; Kersseboom S; Demir K; Catlı G; Yiş U; Böber E; van Mullem A; van Herebeek RE; Hız S; Abacı A; Visser TJ
Horm Res Paediatr; 2014; 82(4):261-71. PubMed ID: 25247785
[TBL] [Abstract][Full Text] [Related]
5. Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter.
Maranduba CM; Friesema EC; Kok F; Kester MH; Jansen J; Sertié AL; Passos-Bueno MR; Visser TJ
J Med Genet; 2006 May; 43(5):457-60. PubMed ID: 15980113
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone transporters.
Visser TJ
Horm Res; 2007; 68 Suppl 5():28-30. PubMed ID: 18174701
[TBL] [Abstract][Full Text] [Related]
7. MCT8: from gene to disease and therapeutic approach.
Kersseboom S; Visser TJ
Ann Endocrinol (Paris); 2011 Apr; 72(2):77-81. PubMed ID: 21511238
[TBL] [Abstract][Full Text] [Related]
8. Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene.
Herzovich V; Vaiani E; Marino R; Dratler G; Lazzati JM; Tilitzky S; Ramirez P; Iorcansky S; Rivarola MA; Belgorosky A
Horm Res; 2007; 67(1):1-6. PubMed ID: 16974106
[TBL] [Abstract][Full Text] [Related]
9. [MCT8-specific thyroid hormone cell transporter deficiency: a case report and review of the literature].
López-Marín L; Martín-Belinchón M; Gutiérrez-Solana LG; Morte-Molina B; Duat-Rodríguez A; Bernal J
Rev Neurol; 2013 Jun; 56(12):615-22. PubMed ID: 23744248
[TBL] [Abstract][Full Text] [Related]
10. X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene.
Brockmann K; Dumitrescu AM; Best TT; Hanefeld F; Refetoff S
J Neurol; 2005 Jun; 252(6):663-6. PubMed ID: 15834651
[TBL] [Abstract][Full Text] [Related]
11. Allan-Herndon-Dudley syndrome (AHDS) in two consecutive generations caused by a missense MCT8 gene mutation. Phenotypic variability with the presence of normal serum T3 levels.
Boccone L; Dessì V; Meloni A; Loudianos G
Eur J Med Genet; 2013 Apr; 56(4):207-10. PubMed ID: 23419639
[TBL] [Abstract][Full Text] [Related]
12. Relevance of different cellular models in determining the effects of mutations on SLC16A2/MCT8 thyroid hormone transporter function and genotype-phenotype correlation.
Capri Y; Friesema EC; Kersseboom S; Touraine R; Monnier A; Eymard-Pierre E; Des Portes V; De Michele G; Brady AF; Boespflug-Tanguy O; Visser TJ; Vaurs-Barriere C
Hum Mutat; 2013 Jul; 34(7):1018-25. PubMed ID: 23568789
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8.
Wémeau JL; Pigeyre M; Proust-Lemoine E; d'Herbomez M; Gottrand F; Jansen J; Visser TJ; Ladsous M
J Clin Endocrinol Metab; 2008 Jun; 93(6):2084-8. PubMed ID: 18334584
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.
Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K
Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548
[TBL] [Abstract][Full Text] [Related]
15. MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression.
Frints SG; Lenzner S; Bauters M; Jensen LR; Van Esch H; des Portes V; Moog U; Macville MV; van Roozendaal K; Schrander-Stumpel CT; Tzschach A; Marynen P; Fryns JP; Hamel B; van Bokhoven H; Chelly J; Beldjord C; Turner G; Gecz J; Moraine C; Raynaud M; Ropers HH; Froyen G; Kuss AW
Eur J Hum Genet; 2008 Sep; 16(9):1029-37. PubMed ID: 18398436
[TBL] [Abstract][Full Text] [Related]
16. Clinical and endocrine features of two Allan-Herndon-Dudley syndrome patients with monocarboxylate transporter 8 mutations.
Kim JH; Kim YM; Yum MS; Choi JH; Lee BH; Kim GH; Yoo HW
Horm Res Paediatr; 2015; 83(4):288-92. PubMed ID: 25896225
[TBL] [Abstract][Full Text] [Related]
17. Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutations.
Visser WE; Jansen J; Friesema EC; Kester MH; Mancilla E; Lundgren J; van der Knaap MS; Lunsing RJ; Brouwer OF; Visser TJ
Hum Mutat; 2009 Jan; 30(1):29-38. PubMed ID: 18636565
[TBL] [Abstract][Full Text] [Related]
18. Severe neurological abnormalities in a young boy with impaired thyroid hormone sensitivity due to a novel mutation in the MCT8 gene.
Rego T; Lado CG; Rodríguez PC; Santos FS; Angueira FB; Castro-Feijóo L; Conde JB; Castro-Gago M
Hormones (Athens); 2017 Apr; 16(2):194-199. PubMed ID: 28742507
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism.
Friesema EC; Kuiper GG; Jansen J; Visser TJ; Kester MH
Mol Endocrinol; 2006 Nov; 20(11):2761-72. PubMed ID: 16887882
[TBL] [Abstract][Full Text] [Related]
20. A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment.
Zung A; Visser TJ; Uitterlinden AG; Rivadeneira F; Friesema EC
Eur J Endocrinol; 2011 Nov; 165(5):823-30. PubMed ID: 21896621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
